FEATURED/ARCHIVES (30/04/24)
Psychosis After Buprenorphine, Heroin, Methadone, Morphine, Oxycodone, and Tramadol Withdrawal: A Systematic Review · July 2021
Articles
European Review for Medical and Pharmacological Sciences
Anti-Inflammatory Effects of Amantadine and Memantine: Possible Therapeutics for the Treatment of Covid-19? · November 2020
Articles
Journal of Personalized Medicine
Long-Term Methylphenidate Exposure and 24-Hours Blood Pressure and Left Ventricular Mass in Adolescents and Young Adults with Attention Deficit Hyperactivity Disorder · October 2022
Articles
European Neuropsychopharmacology
Asenapine Prescribing Patterns in the Treatment of Manic In- and Outpatients: Results from the MANACOR Study · April 2020
Abstracts
European Psychiatry
A Feasibility Study of Patients with Major Depression and Substance Use Disorders: Vortioxetine as Maintenance Treatment · May 2022
Articles
Neuropsychiatric Disease and Treatment
Safety and Cardiovascular Effects of Multiple-Dose Administration of Aripiprazole and Olanzapine in a Randomised Clinical Trial · September 2020
Abstracts
Human Psychopharmacology: Clinical and Experimental
Baseline Levels of C-Reactive Protein and Proinflammatory Cytokines Are Not Associated with Early Response to Amisulpride in Patients with First Episode Psychosis: The OPTiMiSE Cohort Study · May 2021
Articles
Schizophrenia Bulletin Open
Aripiprazole and Risperidone Present Comparable Long-Term Metabolic Profiles: Data from a Pragmatic Randomized Controlled Trial in Drug-Naive First-Episode Psychosis · May 2022
Articles
International Journal of Neuropsychopharmacology
Antidepressant Drugs and COVID-19: A Review of Basic and Clinical Evidence · July 2022
Articles
Journal of Clinical Medicine
Antipsychotic Treatment Effectiveness in First Episode of Psychosis: PAFIP 3-Year Follow-Up Randomized Clinical Trials Comparing Haloperidol, Olanzapine, Risperidone, Aripiprazole, Quetiapine and Ziprasidone · January 2020
Articles
International Journal of Neuropsychopharmacology
Olanzapine-Related Somnambulism: A Systematic Review of Literature and a Case Report of Anorexia Nervosa · November 2021
Abstracts
Journal of Clinical Psychopharmacology
Plasmatic Levels and Response to Variable Doses of Monthly Aripiprazole and Three-Month Paliperidone in Patients with Severe Schizophrenia: Treatment Adherence, Effectiveness, Tolerability, and Safety · October 2023
Articles
Neuropsychiatric Disease and Treatment
Lithium’s Antiviral Effects: A Potential Drug for CoViD-19 Disease? · May 2020
Articles
International Journal of Bipolar Disorders
Long-Term Real-World Effectiveness of Aripiprazole Once-Monthly- Treatment Persistence and Its Correlates in the Italian and Spanish Clinical Practice: A Pooled Analysis · April 2022
Articles
Frontiers in Psychiatry
Differential Response to Donepezil in MRI Subtypes of Mild Cognitive Impairment · June 2023
Articles
Alzheimer’s Research and Therapy
Intepirdine as Adjunctive Therapy to Donepezil for Mild-to-Moderate Alzheimer’s Disease: A Randomized, Placebo-Controlled, Phase 3 Clinical Trial (MINDSET) · May 2021
Articles
Alzheimer’s and Dementia: Translational Research and Clinical Interventions
Impact on Functionality of the Paliperidone Palmitate Three-Month Formulation in Patients with a Recent Diagnosis of Schizophrenia: A Real-World Observational Prospective Study · January 2022
Articles
Expert Opinion on Pharmacotherapy
Successful High Dose Antipsychotic Treatment with Cariprazine in Patients on the Schizophrenia Spectrum: Real-World Evidence from a Spanish Hospital Setting · February 2023
Articles
Frontiers in Psychiatry
A Guideline and Checklist for Initiating and Managing Clozapine Treatment in Patients with Treatment-Resistant Schizophrenia · June 2022
Articles
CNS Drugs
Aripiprazole as a Candidate Treatment of COVID-19 Identified through Genomic Analysis · March 2021
Articles
Frontiers in Pharmacology